These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17368959)

  • 41. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).
    Jun H; Seo SK; Jeong HY; Seo HM; Zhu G; Chen L; Choi IH
    FEBS Lett; 2005 Nov; 579(27):6259-64. PubMed ID: 16253242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of the Cytokine VEGF-A by CD4
    Yun H; Yee MB; Lathrop KL; Kinchington PR; Hendricks RL; St Leger AJ
    Immunity; 2020 Nov; 53(5):1050-1062.e5. PubMed ID: 33207210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI; Kim SW; Kim S; Kim T; Kim EK
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
    Thomas J; Rouse BT
    J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo observations and electron microscopy of treatment of experimental HSV keratitis with anti-HSV monoclonal antibodies.
    Yu J; Zhang Y; Zhang D
    Yan Ke Xue Bao; 1996 Sep; 12(3):145-50. PubMed ID: 9639841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
    Lee S; Zheng M; Kim B; Rouse BT
    J Clin Invest; 2002 Oct; 110(8):1105-11. PubMed ID: 12393846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy.
    Rajasagi NK; Rouse BT
    Microbes Infect; 2018; 20(9-10):526-530. PubMed ID: 29329934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis.
    Biswas PS; Banerjee K; Kim B; Smith J; Rouse BT
    Exp Eye Res; 2005 Jan; 80(1):73-81. PubMed ID: 15652528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9.
    Hayashi K; Hooper LC; Detrick B; Hooks JJ
    Arch Virol; 2009; 154(2):219-26. PubMed ID: 19115032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vivo observations and electron microscopy in the treatment of experimental HSV keratitis with monoclonal antibodies].
    Yu J; Zhang YH; Zhang DG
    Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):221-4. PubMed ID: 7843007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
    Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
    J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein.
    Biswas PS; Banerjee K; Zheng M; Rouse BT
    J Leukoc Biol; 2004 Oct; 76(4):868-75. PubMed ID: 15258192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo immunofluorescence to diagnose herpes simplex virus keratitis in mice.
    Sharma A; Shimeld C
    Br J Ophthalmol; 1997 Sep; 81(9):785-8. PubMed ID: 9422934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acyclovir for the treatment and prevention of recurrent infectious herpes simplex keratitis.
    Wu X; Chen X
    Chin Med J (Engl); 2002 Oct; 115(10):1569-72. PubMed ID: 12490113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic anti-VEGF antibodies.
    Lien S; Lowman HB
    Handb Exp Pharmacol; 2008; (181):131-50. PubMed ID: 18071944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
    Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topical use of rapamycin in herpetic stromal keratitis.
    Zapata G; Racca L; Tau J; Berra A
    Ocul Immunol Inflamm; 2012 Oct; 20(5):354-9. PubMed ID: 23030354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice.
    Yao HW; Chen SH; Li C; Tung YY; Chen SH
    J Virol; 2012 Aug; 86(16):8559-67. PubMed ID: 22647700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel rare sugar inhibitor of murine herpes simplex keratitis.
    Muniruzzaman S; McIntosh M; Hossain A; Izumori K; Bhattacharjee PS
    J Pharmacol Sci; 2016 Jun; 131(2):126-30. PubMed ID: 27262904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.
    Kim B; Tang Q; Biswas PS; Xu J; Schiffelers RM; Xie FY; Ansari AM; Scaria PV; Woodle MC; Lu P; Rouse BT
    Am J Pathol; 2004 Dec; 165(6):2177-85. PubMed ID: 15579459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.